BioNTech SE (LTS:0A3M)
$ 112.3 4.95 (4.61%) Market Cap: 26.92 Bil Enterprise Value: 8.65 Bil PE Ratio: 0 PB Ratio: 1.25 GF Score: 63/100

Q1 2022 BioNTech SE Earnings Call Transcript

May 09, 2022 / 12:00PM GMT
Release Date Price: $144.9 (+5.71%)
Operator

Welcome to the BioNTech First Quarter 2022 Update Call. I would like to hand the call over to the Vice President of Investor Relations and Strategy, Sylke Maas. Please go ahead, Sylke.

Sylke Maas
BioNTech SE - VP of IR and Business Strategy

Good morning and good afternoon, and thank you for joining us today to review BioNTech's First Quarter 2022 Clinical and Operational Progress and Financial Results. A few housekeeping items before we start. Please view the slides that accompany the webcast in the first quarter 2022 press release, both were issued this morning and can be found in the Investors section of our website.

As outlined on Slide 2, today's presentation, we'll be making several forward-looking statements. These forward-looking statements include, but are not limited to, our current COVID-19 vaccine revenues as they include figures that are derived from preliminary estimates provided by our partners, our estimated financial results for 2022, the continued global demand for our COVID-19 vaccine, our target vaccine production capacity for 2022

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot